The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been trading flat at around 8,280 points.

Mesoblast (ASX:MSB) has been the most watched on HotCopper so far today on news it’s received seven years of orphan-drug exclusive approval from the U.S. Food and Drug Administration.

Mesoblast has been $1.74.

WA1 Resources (ASX:WA1) has also been trending after Project Lumi’s assay results from resource definition drilling across the west of Luni achieved the best results to date.

WA1 Resources has been $12.28.

And, finally Anson Resources (ASX:ASN) has received the green light to commence a drilling program at its Green River Lithium Project (Project) in south-eastern Utah, USA.

Anson Resources has been 5.3 cents.

More From The Market Online

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk
The Market Online Video

Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale

We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
The Market Online Video

US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27

AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre.